Portage Biotech Statistics Share Statistics Portage Biotech has 2.28M
shares outstanding. The number of shares has increased by 6.89%
in one year.
Shares Outstanding 2.28M Shares Change (YoY) 6.89% Shares Change (QoQ) 0% Owned by Institutions (%) 10.71% Shares Floating 559.08K Failed to Deliver (FTD) Shares 65 FTD / Avg. Volume 0.06%
Short Selling Information The latest short interest is 36.16K, so 1.59% of the outstanding
shares have been sold short.
Short Interest 36.16K Short % of Shares Out 1.59% Short % of Float 4.16% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.99 and the forward
PE ratio is -0.65.
Portage Biotech's PEG ratio is
0.07.
PE Ratio -2.99 Forward PE -0.65 PS Ratio 0 Forward PS n/a PB Ratio 55.94 P/FCF Ratio -15.74 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Portage Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.67,
with a Debt / Equity ratio of 0.01.
Current Ratio 2.67 Quick Ratio 2.67 Debt / Equity 0.01 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -570.41
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-10.76M Employee Count 7 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -10.55M Effective Tax Rate 12.31%
Stock Price Statistics The stock price has increased by 93.47% in the
last 52 weeks. The beta is 0.64, so Portage Biotech's
price volatility has been higher than the market average.
Beta 0.64 52-Week Price Change 93.47% 50-Day Moving Average 6.84 200-Day Moving Average 6.13 Relative Strength Index (RSI) 40.98 Average Volume (20 Days) 117,785
Income Statement
Revenue n/a Gross Profit -54K Operating Income -18.25M Net Income -75.34M EBITDA -18.2M EBIT -18.25M Earnings Per Share (EPS) -3.7
Full Income Statement Balance Sheet The company has 5.03M in cash and 47K in
debt, giving a net cash position of 4.98M.
Cash & Cash Equivalents 5.03M Total Debt 47K Net Cash 4.98M Retained Earnings -239.32M Total Assets 2.71M Working Capital 1.81M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.3M
and capital expenditures 0, giving a free cash flow of -14.3M.
Operating Cash Flow -14.3M Capital Expenditures n/a Free Cash Flow -14.3M FCF Per Share -0.7
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PRTG does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for PRTG.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 15, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Aug 15, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -213.9 Piotroski F-Score 3
